1. Home
  2. METC vs ANNX Comparison

METC vs ANNX Comparison

Compare METC & ANNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ramaco Resources Inc.

METC

Ramaco Resources Inc.

HOLD

Current Price

$15.49

Market Cap

1.0B

Sector

Energy

ML Signal

HOLD

Logo Annexon Inc.

ANNX

Annexon Inc.

HOLD

Current Price

$5.65

Market Cap

972.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
METC
ANNX
Founded
2015
2011
Country
United States
United States
Employees
900
N/A
Industry
Coal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
972.5M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
METC
ANNX
Price
$15.49
$5.65
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
6
Target Price
$34.00
$16.50
AVG Volume (30 Days)
1.2M
2.0M
Earning Date
05-08-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$19.61
N/A
Revenue Next Year
$11.96
$16,320.74
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.51
$1.85
52 Week High
$57.80
$7.18

Technical Indicators

Market Signals
Indicator
METC
ANNX
Relative Strength Index (RSI) 56.74 45.94
Support Level $15.08 $4.79
Resistance Level $15.98 $6.56
Average True Range (ATR) 0.86 0.29
MACD 0.14 -0.06
Stochastic Oscillator 90.96 34.21

Price Performance

Historical Comparison
METC
ANNX

About METC Ramaco Resources Inc.

Ramaco Resources Inc is a United States-based company that operates as a pure-play metallurgical coal company with operations in southern West Virginia and southwestern Virginia. Its portfolio includes high-quality metallurgical coal reserves & resources, with a focus on properties such as Elk Creek, Berwind, Knox Creek, and Maben. These properties are strategically located to serve North American blast furnace steel mills and coke plants, as well as international metallurgical coal consumers. Additionally, the company controls mineral deposits in Sheridan, Wyoming, exploring potential opportunities in rare earth elements and coal-to-carbon-based products. The company's two operating segments are Metallurgical Coal segment; and Rare Earths and Critical Minerals.

About ANNX Annexon Inc.

Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502, for Oral small molecule; and ANX009, for systemic autoimmune diseases.

Share on Social Networks: